We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Immunodiagnostic Systems Holdings Plc | LSE:IDH | London | Ordinary Share | GB00B01YZ052 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 378.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMIDH
RNS Number : 4881T
Immunodiagnostic Systems Hldgs PLC
05 January 2017
For filings with the FSA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) ------------------------------------------------------------------------------------------------------------ 1. Identity of the issuer or Immunodiagnostic Systems the underlying issuer Holdings PLC of existing shares to which voting rights are attached: (ii) ------------------------------------------------------------- --------------------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): ------------------------------------------------------------------------------------------------------------ An acquisition or disposal of voting rights yes ---------------------------------------------------------------- ------------------------------------------ An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ---------------------------------------------------------------- ------------------------------------------ An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ---------------------------------------------------------------- ------------------------------------------ An event changing the breakdown of voting rights ---------------------------------------------------------------- ------------------------------------------ Other (please specify): ------------------------------------------------------- ------- ------------------------------------------ 3. Full name of person(s) Polar Capital European Forager subject to the Fund Limited notification obligation: (iii) --------------------------------------------------------- ------------------------------------------------- 4. Full name of shareholder(s) (if different from 3.):(iv) --------------------------------------------------------- ------------------------------------------------- 5. Date of the transaction 04.01.2017 and date on which the threshold is crossed or reached: (v) --------------------------------------------------------- ------------------------------------------------- 6. Date on which issuer 05.01.2017 notified: --------------------------------------------------------- ------------------------------------------------- 7. Threshold(s) that is/are <5%,<4% crossed or reached: (vi, vii) --------------------------------------------------------- -------------------------------------------------
"
8. Notified details: ---------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) ---------------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE ------------- ---------------------------------- ------------------------------------------------------------------- Number Number Number Number of % of voting of of of shares voting rights (x) Shares Voting rights Rights ------------- ---------------- ---------------- -------------- -------------------------- ----------------------- Direct Direct Indirect Direct Indirect (xi) (xii) ------------- ------------ ------------ -------------- ------------ ------------ ---------- ----------- GB00B01YZ052 1,543,572 1,543,572 1,143,572 1,143,572 3.88% ---------------- ---------------- -------------- ------------ ------------ ---------- ----------- B: Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. ----------------- -------------- -------------------------------- -------------------------- --------------------- n/a ----------------- -------------- -------------------------------- -------------------------- --------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights (xix, instrument (xvii) period refers to xx) (xviii) --------------- -------------- -------------- -------------- ---------------------------- ----------------------- n/a Nominal Delta --------------- -------------- -------------- -------------- ---------------------------- ------------ --------- Total (A+B+C) ---------------------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights --------------------------------------------------------------- ----------------------------------------------------- 1,143,572 3.88% --------------------------------------------------------------- ----------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) ----------------------------------------------------------------------------------------------- Proxy Voting: ----------------------------------------------------------------------------------------------- 10. Name of the proxy holder: ------------------------------------------------------------- -------------------------------- 11. Number of voting rights proxy holder will cease to hold: ------------------------------------------------------------- -------------------------------- 12. Date on which proxy holder will cease to hold voting rights: ------------------------------------------------------------- -------------------------------- 13. Additional information: Polar Capital LLP - Operations Department ------------------------------------------------------------- -------------------------------- 14. Contact name: Stephen Amoah ------------------------------------------------------------- -------------------------------- 15. Contact telephone number: +44 (0)207 227 2768 ------------------------------------------------------------- --------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUVOBRBOAARAR
(END) Dow Jones Newswires
January 05, 2017 12:35 ET (17:35 GMT)
1 Year Immunodiagnostic Systems Chart |
1 Month Immunodiagnostic Systems Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions